Cancer Medicine Journal (launched in May 2018) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.
Cancer Medicine Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.
Michael J Dochniak
Muhammad Shahid Iqbal, Alastair Greystoke and John Byrne
Subodh K Regmi, Song Jiang and Christopher A. Warlick
Jihene Ayari, Sarra Karrit, Shourouk Haj Ammar, Mehdi Bouhlel, Mehdi Balti, Aref Zribi, Sana Fendri, Sonia Ben Nasr, Oussama Belamine, Mouna Ben Azaiz, Ezzedine Ghazouani, Lotfi Massoudi, Faida Agili Sharif Kullab and Abderrazek Haddaoui
Suresh Rao, Sanath Hegde, Pratima Rao, Prajna D’silva, Rhea Katherin D’souza, Manoj Ponadka Rai and Manjeshwar Shrinath Baliga
Vsevolod Dolhyi, Dmytro Avierin and Mohammad Hojouj
Rahat Hashmi and Fahim Ahmad
Ayman Rasmy, Amal Ameen and Amira AbdMonem
Barry Meisenberg, Jane Rhule RN, Jessica Tan, Laura Arvin and Susanne Tameris
Bader A Abdelmaksoud, Fayez G Alruwaily, Zaki Alalem and Ahmad A Dafaallah
Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.
The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: